[
    "{\"step_by_step_thinking\": \"Based on the information provided in the relevant documents, AZD5153 is a novel BRD4 inhibitor that has shown promising therapeutic value against prostate cancer cells. It has been shown to inhibit proliferation and survival of prostate cancer cells, induce apoptosis activation and cell cycle arrest, and downregulate BRD4 targets in prostate cancer cells. In addition, AZD5153 has demonstrated anti-tumor activity in vivo in a PC-3 xenograft model. Therefore, the answer is A. yes, AZD5153 is active in prostate cancer.\", \"answer_choice\": \"A\"}"
]